Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey...
